Previous close | 83.25 |
Open | 82.75 |
Bid | 84.20 x 0 |
Ask | 84.30 x 0 |
Day's range | 82.55 - 83.35 |
52-week range | 73.42 - 122.85 |
Volume | |
Avg. volume | 34 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and data-driven workflow for ophthalmologists, supported by the largest OCT (optical coherence tomography) reference database in the U.S. market, as well as newly enhanced cybersecurity features. As part of the ZEISS Medical Ecosystem, the latest OCT device from ZEISS, which recently received clearance by the U.S. Food and Drug Administration (FDA), helps support informed, data-driven patient
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Carl Zeiss Meditec ( ETR:AFX ) Second Quarter 2024 Results Key Financial Results Revenue: €472.1m (down 6.4% from 2Q...